Galecto (GLTO) Investor Presentation - Slideshow

·♪Galecto First-in-class small-molecule anti-fibrotic and anti-cancer agents May 2021 Forward-looking statements This presentation contains forward-looking statements that involve substantial risks and uncertainties. All statements, other than statements of historical facts, contained in this presentation, including statements regarding Galecto, Inc.'s (the "Company") strategy, future operations, future financial position, projected costs, prospects, plans, and objectives, are forward-looking statements. Su ...